- Home
- CGEM vs AIO Comparison
CGEM vs AIO Comparison
Compare CGEM & AIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- AIO
- Stock Information
- Founded
- CGEM 2016
- AIO 2019
- Country
- CGEM United States
- AIO United States
- Employees
- CGEM N/A
- AIO N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- AIO Finance/Investors Services
- Sector
- CGEM Health Care
- AIO Finance
- Exchange
- CGEM Nasdaq
- AIO Nasdaq
- Market Cap
- CGEM 730.2M
- AIO 872.3M
- IPO Year
- CGEM 2021
- AIO N/A
- Fundamental
- Price
- CGEM $10.55
- AIO $25.34
- Analyst Decision
- CGEM Strong Buy
- AIO
- Analyst Count
- CGEM 7
- AIO 0
- Target Price
- CGEM $31.67
- AIO N/A
- AVG Volume (30 Days)
- CGEM 551.6K
- AIO 141.5K
- Earning Date
- CGEM 03-13-2025
- AIO 01-01-0001
- Dividend Yield
- CGEM N/A
- AIO 9.05%
- EPS Growth
- CGEM N/A
- AIO N/A
- EPS
- CGEM N/A
- AIO N/A
- Revenue
- CGEM N/A
- AIO N/A
- Revenue This Year
- CGEM N/A
- AIO N/A
- Revenue Next Year
- CGEM N/A
- AIO N/A
- P/E Ratio
- CGEM N/A
- AIO N/A
- Revenue Growth
- CGEM N/A
- AIO N/A
- 52 Week Low
- CGEM $9.50
- AIO $15.09
- 52 Week High
- CGEM $30.19
- AIO $20.25
- Technical
- Relative Strength Index (RSI)
- CGEM 38.45
- AIO 64.36
- Support Level
- CGEM $10.14
- AIO $23.90
- Resistance Level
- CGEM $11.31
- AIO $24.64
- Average True Range (ATR)
- CGEM 0.64
- AIO 0.55
- MACD
- CGEM 0.01
- AIO 0.13
- Stochastic Oscillator
- CGEM 30.11
- AIO 92.86
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About AIO Virtus Artificial Intelligence & Technology Opportunities Fund of Beneficial Interest
Virtus Artificial Intelligence & Technology Opportunities Fund is a diversified, limited-term closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation.